Starpharma Holdings reported AUD417K in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesoblast USD 9.06M 16.67M Jun/2026
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025